Table 1 Demographic data and AWS severity at baseline
Group D (DEX) | Group C (control) | p value | |
|---|---|---|---|
Male | 33/35 (94) | 28/32 (88) | 0.9 |
Age, median (IQR) | 46.5 (43–50) | 46 (42–50) | 1.0 |
Comorbidity | |||
Liver cirrhosis | |||
Child-Pugh A, n (%) | 1/35 (3) | 1/32 (3) | 1.0 |
Child-Pugh B, n (%) | 2/35 (6) | 1/32 (3) | 0.9 |
Pneumonia, n (%) | 1/35 (3) | 0/32 | 1.0 |
Diabetes, n (%) | 1/35 (3) | 2/32 (6) | 0.9 |
Congestive heart failure | |||
NYHA class I | 1/35 (3) | 1/32 (3) | 1.0 |
NYHA class II | 1/35 (3) | 1/32 (3) | 1.0 |
Arterial hypertension n (%) | 3/35 (9) | 6/32 (19) | 0.19 |
Other | |||
Leg fracture, n (%) | 2/35 (6) | 0/32 | 1.0 |
Acute pancreatitis, n (%) | 1/35 (3) | 2/32 (6) | 1.0 |
CIWA-Ar at ICU admission, median (IQR) | 25 (18 to 29) | 26 (17–28) | 1.0 |
RASS at ICU admission, median (IQR) | +2 (+1 to +3) | +2 (+1 to +3) | 1.0 |
Diazepam dose administered prior to study enrollment, mg, median (IQR) | 30 (20–40) | 30 (20–40) | 1.0 |